Myelodysplastic-Myeloproliferative Diseases - 21 Studies Found
Terminated |
: Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes :
|
Completed |
: Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes :
: 2004-12-07 : Drug: amifostine trihydrate |
Completed |
: Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes :
|
Completed |
: Cholecalciferol in Treating Patients With Myelodysplastic Syndrome :
|
Completed |
: 3-AP and Cytarabine in Treating Patients With Hematologic Cancer :
|
Completed |
: Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome :
: 2002-10-03 :
|
Completed |
: Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions :
|
Completed |
: Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer :
|
Completed |
: Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat Higher Risk Myelodysplastic Syndromes :
|